Generics Industry Braces For New Wave Of Price Pressure

US Price Erosion Set For Double-Digits; Pricing And Costs Bite In Europe

With pricing pressures already creeping up in recent years, 2022 is set to see the generics industry caught in the middle as prices are further squeezed while costs continue to rise. As major players prepare to announce their first-quarter financial results, Generics Bulletin looks at views from industry leaders on how these pressures are affecting their businesses, and how they can be expected to play out.

Dollar Sign in Vise Vice Price Squeeze
Industry faces pressure as prices are squeezed and costs rise • Source: Design Pics / Alamy Stock Photo

More from Drug Pricing

More from Policy & Regulation